AnheuserBusch InBev (BUD)
(Delayed Data from NYSE)
$61.69 USD
+0.72 (1.18%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $61.68 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$61.69 USD
+0.72 (1.18%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $61.68 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth A Momentum A VGM
Zacks News
Business Momentum & Diversification to Support FEMSA (FMX)
by Zacks Equity Research
FEMSA (FMX) looks poised for growth on its diversified business portfolio, growth in digital business and expansion in the specialized distribution business.
How Constellation Brands (STZ) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q2 results to reflect continued gains from strong demand for its premium portfolio and strength in the beer business amid rising costs and supply-chain challenges.
Digital Investments & Premiumization to Aid AB InBev (BUD)
by Zacks Equity Research
AB InBev (BUD) looks well-poised based on a strong brand portfolio and investments in operation excellence. Higher cost of sales and SG&A expenses remain headwinds.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Consumer Staples
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Can AB InBev's (BUD) Strategies Aid Growth Amid Rising Costs?
by Zacks Equity Research
AB InBev (BUD) looks poised to retain its business momentum on the expansion of the Beyond Beer portfolio, digital growth and investments in operation excellence amid high costs and supply-chain woes.
4 Lucrative Alcohol Stocks to Watch as Industry Trends Recover
by Rajani Lohia
The Beverages - Alcohol industry looks poised to gain from strong on-premise and off-premise demand, recovery in Travel Retail, innovation, and premiumization despite supply-chain disruptions. Players like DEO, BUD, STZ and BF.B will likely capitalize on the trends.
The Zacks Analyst Blog Highlights Alphabet, The Goldman Sachs, Anheuser-Busch, PayPal and Duke Energy
by Zacks Equity Research
Alphabet, The Goldman Sachs, Anheuser-Busch, PayPal and Duke Energy are part of The Zacks top Analyst blog.
Top Analyst Reports for Alphabet, Goldman Sachs & Anheuser-Busch
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), The Goldman Sachs Group, Inc. (GS) and Anheuser-Busch InBev SA/NV (BUD).
Top Research Reports for Amazon.com, Berkshire Hathaway & Thermo Fisher
by Santanu Roy
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Thermo Fisher Scientific Inc. (TMO).
AB InBev (BUD) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
AB InBev's (BUD) Q2 results reflect gains from investment in brands, the robust execution of strategies and growth in the digital business. Supply-chain woes continue to mar margins.
The Zacks Analyst Blog Highlights Johnson & Johnson, Advanced Micro Devices, Union Pacific, Anheuser-Busch, and ServiceNow
by Zacks Equity Research
Johnson & Johnson, Advanced Micro Devices, Union Pacific, Anheuser-Busch, and ServiceNow are part of Zacks top Analyst Blog.
Q2 Earnings Season Preview and Featured Analyst Reports for J&J, AMD & Union Pacific
by Sheraz Mian
Today's Research Daily features preview of the Q2 earnings season and new research reports for J&J (JNJ), AMD (AMD), and Union Pacific (UNP).
Cross Country Healthcare and AnheuserBusch InBev have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cross Country Healthcare and AnheuserBusch InBev are part of Zacks Bull and Bear of the Day article.
Bear Of The Day: AnheuserBusch InBev (BUD)
by Brian Bolan
BUD may have beaten the number, but the EPS estimates for this stock keep dipping lower.
AB InBev (BUD) Surpasses Sales & Earnings Estimates in Q1
by Zacks Equity Research
AB InBev's (BUD) Q1 results reflect continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?
by Zacks Equity Research
AB InBev's (BUD) Q1 results are expected to reflect gains from volume, pricing and revenue per hl growth, as well as strength in the beer category, amid supply-chain and cost headwinds.
AB InBev (BUD) Q4 Sales & Earnings Beat on Business Momentum
by Zacks Equity Research
AB InBev (BUD) Q4 results reflect continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
Things to Note Before AB InBev (BUD) Reports Q4 Earnings
by Zacks Equity Research
AB InBev (BUD) Q4 results are likely to reflect gains from business momentum, brand investments and digital growth, amid increasing inflationary costs and adverse currency translations.
Top Stock Reports for NVIDIA, UPS & Intuit
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), United Parcel Service, Inc. (UPS), and Intuit Inc. (INTU).
Factors to Note Ahead of Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are likely to reflect gains from strong consumer demand, and productivity and cost-saving initiatives. Higher input and freight costs are likely to have ailed.
The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, Abbott Laboratories, T-Mobile, Anheuser-Busch and Boston Scientific Corp
Top Analyst Reports for Alibaba, Abbott & T-Mobile US
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Abbott Laboratories (ABT), and T-Mobile US, Inc. (TMUS).
AB InBev (BUD) Q3 Earnings Lag Estimates, Revenues Beat
by Zacks Equity Research
AB InBev (BUD) reports top-line growth in Q3, driven by a favorable combination of volume and pricing. The bottom line reflects the impacts of higher costs and supply-chain disruptions.
Factors Likely to Decide the Fate of AB InBev (BUD) in Q3
by Zacks Equity Research
Commodity cost inflation, adverse currency and higher SG&A expenses are expected to have hurt AB InBev (BUD) in Q3. Strong brand portfolio and digital growth are likely to have aided.
Boson Beer (SAM) Posts Q3 Loss on Soft Hard Seltzer Trends
by Zacks Equity Research
Boston Beer's (SAM) Q3 results reflect the impacts of the slowdown in hard seltzer category trends as well as higher operating costs.